SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS
The invention discloses chemical entity of Formula (I) in which V, W, Y, and Z have any of the values described herein, and compositions comprising such chemical entities, methods of making them; andtheir use in a wide range of methods, including metabolic and reaction kinetic studies; detection and...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | VERNIER WILLIAM FRANCOIS GOMEZ LAURENT |
| description | The invention discloses chemical entity of Formula (I) in which V, W, Y, and Z have any of the values described herein, and compositions comprising such chemical entities, methods of making them; andtheir use in a wide range of methods, including metabolic and reaction kinetic studies; detection and imaging techniques, radioactive treatments; modulating and treating disorders mediated by PDE2 activity; treating neurological disorders, CNS disorders, dementia, cognitive disorders, neurodegenerative diseases, and trauma-dependent losses of function, enhancing the efficiency of cognitive and motor training, including in stroke or TBI rehabilitation; and treating peripheral disorders, including hematological, cardiovascular, gastroenterological, dermatoiogical, inflammatory, and pain disorders.
通式(I)的化学实体：其中V、W、Y和Z具有本文所述的任何值，和包含此化学实体的组合物，制备它们的方法；以及它们在各种方法中的应用，包括代谢和反应动力学研究；检测和成像技术；放射性治疗；调节和治疗由PDE2活性介导的病症；治疗神经学病症、CNS病症、痴呆、认知障碍、神经退行性疾病和创伤依赖性功能丧失；提高包括脑卒中或TBI康复中的训练在内的认知和运动训练的效率；并且治疗外周病症，包括血液学病症、心血管病症、胃肠道病学病症、皮肤病学病症、炎症 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN110337437A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN110337437A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN110337437A3</originalsourceid><addsrcrecordid>eNrjZLANDnUKDvEMCQ1xdVEIiAxyjPL38QfSnr6eLp5-_n6uCs7-vgH-oX4uwQqOwQoBLq5GCp5-Hp5OniH-QcE8DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSTe2c_Q0MDY2NzE2NzRmBg1AJCsKoc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS</title><source>esp@cenet</source><creator>VERNIER WILLIAM FRANCOIS ; GOMEZ LAURENT</creator><creatorcontrib>VERNIER WILLIAM FRANCOIS ; GOMEZ LAURENT</creatorcontrib><description>The invention discloses chemical entity of Formula (I) in which V, W, Y, and Z have any of the values described herein, and compositions comprising such chemical entities, methods of making them; andtheir use in a wide range of methods, including metabolic and reaction kinetic studies; detection and imaging techniques, radioactive treatments; modulating and treating disorders mediated by PDE2 activity; treating neurological disorders, CNS disorders, dementia, cognitive disorders, neurodegenerative diseases, and trauma-dependent losses of function, enhancing the efficiency of cognitive and motor training, including in stroke or TBI rehabilitation; and treating peripheral disorders, including hematological, cardiovascular, gastroenterological, dermatoiogical, inflammatory, and pain disorders.
通式(I)的化学实体：其中V、W、Y和Z具有本文所述的任何值，和包含此化学实体的组合物，制备它们的方法；以及它们在各种方法中的应用，包括代谢和反应动力学研究；检测和成像技术；放射性治疗；调节和治疗由PDE2活性介导的病症；治疗神经学病症、CNS病症、痴呆、认知障碍、神经退行性疾病和创伤依赖性功能丧失；提高包括脑卒中或TBI康复中的训练在内的认知和运动训练的效率；并且治疗外周病症，包括血液学病症、心血管病症、胃肠道病学病症、皮肤病学病症、炎症</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191015&DB=EPODOC&CC=CN&NR=110337437A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191015&DB=EPODOC&CC=CN&NR=110337437A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VERNIER WILLIAM FRANCOIS</creatorcontrib><creatorcontrib>GOMEZ LAURENT</creatorcontrib><title>SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS</title><description>The invention discloses chemical entity of Formula (I) in which V, W, Y, and Z have any of the values described herein, and compositions comprising such chemical entities, methods of making them; andtheir use in a wide range of methods, including metabolic and reaction kinetic studies; detection and imaging techniques, radioactive treatments; modulating and treating disorders mediated by PDE2 activity; treating neurological disorders, CNS disorders, dementia, cognitive disorders, neurodegenerative diseases, and trauma-dependent losses of function, enhancing the efficiency of cognitive and motor training, including in stroke or TBI rehabilitation; and treating peripheral disorders, including hematological, cardiovascular, gastroenterological, dermatoiogical, inflammatory, and pain disorders.
通式(I)的化学实体：其中V、W、Y和Z具有本文所述的任何值，和包含此化学实体的组合物，制备它们的方法；以及它们在各种方法中的应用，包括代谢和反应动力学研究；检测和成像技术；放射性治疗；调节和治疗由PDE2活性介导的病症；治疗神经学病症、CNS病症、痴呆、认知障碍、神经退行性疾病和创伤依赖性功能丧失；提高包括脑卒中或TBI康复中的训练在内的认知和运动训练的效率；并且治疗外周病症，包括血液学病症、心血管病症、胃肠道病学病症、皮肤病学病症、炎症</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLANDnUKDvEMCQ1xdVEIiAxyjPL38QfSnr6eLp5-_n6uCs7-vgH-oX4uwQqOwQoBLq5GCp5-Hp5OniH-QcE8DKxpiTnFqbxQmptB0c01xNlDN7UgPz61uCAxOTUvtSTe2c_Q0MDY2NzE2NzRmBg1AJCsKoc</recordid><startdate>20191015</startdate><enddate>20191015</enddate><creator>VERNIER WILLIAM FRANCOIS</creator><creator>GOMEZ LAURENT</creator><scope>EVB</scope></search><sort><creationdate>20191015</creationdate><title>SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS</title><author>VERNIER WILLIAM FRANCOIS ; GOMEZ LAURENT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN110337437A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VERNIER WILLIAM FRANCOIS</creatorcontrib><creatorcontrib>GOMEZ LAURENT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VERNIER WILLIAM FRANCOIS</au><au>GOMEZ LAURENT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS</title><date>2019-10-15</date><risdate>2019</risdate><abstract>The invention discloses chemical entity of Formula (I) in which V, W, Y, and Z have any of the values described herein, and compositions comprising such chemical entities, methods of making them; andtheir use in a wide range of methods, including metabolic and reaction kinetic studies; detection and imaging techniques, radioactive treatments; modulating and treating disorders mediated by PDE2 activity; treating neurological disorders, CNS disorders, dementia, cognitive disorders, neurodegenerative diseases, and trauma-dependent losses of function, enhancing the efficiency of cognitive and motor training, including in stroke or TBI rehabilitation; and treating peripheral disorders, including hematological, cardiovascular, gastroenterological, dermatoiogical, inflammatory, and pain disorders.
通式(I)的化学实体：其中V、W、Y和Z具有本文所述的任何值，和包含此化学实体的组合物，制备它们的方法；以及它们在各种方法中的应用，包括代谢和反应动力学研究；检测和成像技术；放射性治疗；调节和治疗由PDE2活性介导的病症；治疗神经学病症、CNS病症、痴呆、认知障碍、神经退行性疾病和创伤依赖性功能丧失；提高包括脑卒中或TBI康复中的训练在内的认知和运动训练的效率；并且治疗外周病症，包括血液学病症、心血管病症、胃肠道病学病症、皮肤病学病症、炎症</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN110337437A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T09%3A29%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VERNIER%20WILLIAM%20FRANCOIS&rft.date=2019-10-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN110337437A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |